Patent details

EP3131874 Title: NOVEL CANNABIDIOL QUINONE DERIVATIVES

Basic Information

Publication number:
EP3131874
PCT Application Number:
EP2014057767
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147233456
PCT Publication Number:
WO2015158381
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL CANNABIDIOL QUINONE DERIVATIVES
French Title of Invention:
NOUVEAUX DÉRIVÉS QUINONE DU CANNABIDIOL
German Title of Invention:
NEUARTIGE CANNABIDIOL-CHINON-DERIVATE
SPC Number:

Dates

Filing date:
16/04/2014
Grant date:
25/07/2018
EP Publication Date:
22/02/2017
PCT Publication Date:
22/10/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/07/2018
EP B1 Publication Date:
25/07/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/04/2019
Expiration date:
16/04/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/07/2018
 
 

Name:
Emerald Health Pharmaceuticals Inc.
Address:
5820 Nancy Ridge Drive, San Diego, CA 92121, United States (US)

Inventor

1

Name:
BELLIDO CABELLO DE ALBA, María Luz
Address:
Spain (ES)

2

Name:
APPENDINO, Giovanni
Address:
Italy (IT)

3

Name:
MUÑOZ BLANCO, Eduardo
Address:
Spain (ES)

Classification

IPC classification:
C07C 69/75; C07C 225/28;

Publication

European Patent Bulletin

Issue number:
201830
Publication date:
25/07/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages